Garry Menzel

Garry Menzel

Directeur/Membre du Conseil chez BLACK DIAMOND THERAPEUTICS, INC.

Fortune : 152 233 $ au 31/10/2026

61 ans
Health Technology
Consumer Services
Finance

Profil

Garry E.
Menzel
is an Independent Director at Black Diamond Therapeutics, Inc. since 2017.
Holds director roles at Epilepsy Therapy Project and Roslin Cell Therapies Ltd. (starting 2025).
Serves as Independent Non-Executive Director at Adaptimmune Therapeutics Plc since 2023.
Member of the National Board at Epilepsy Foundation since 2003.
Principal at Royal College of Art.
Formerly President, Chief Executive Officer & Director at TCR² Therapeutics, Inc. from 2016 to 2023.
Managing Director at Credit Suisse Group AG in 2008.
Managing Director at The Goldman Sachs Group, Inc. in 2004.
Director at Institute for Systems Biology.
Independent Director at Stoke Therapeutics, Inc. from 2020 to 2026.
Chief Financial Officer at DaVita, Inc. from 2013 to 2015.
Chief Operating Officer at Regulus Therapeutics, Inc. from 2012 to 2013.
Chief Strategy Officer at Axcella Health, Inc. from 2015 to 2016.
Research Assistant at Smithkline Beecham Plc from 2004 to 2008.
Consultant at Bain & Co., Inc. from 1994 to 2004.
Operating Partner at GHO Capital Partners LLP from 2024 to 2026.
Education includes an undergraduate degree from Imperial College London (1985), a doctorate from the University of Cambridge (1988), and an MBA from Stanford Graduate School of Business (1994).

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/06/2026 76 664 ( 0,13 % ) 136 462 $ 31/10/2026
11/04/2025 4 117 680 ( 0,26 % ) 15 771 $ 31/10/2026
31/03/2026 0 ( -.--% ) - $ 31/10/2026

Postes actifs de Garry Menzel

SociétésPosteDébut
BLACK DIAMOND THERAPEUTICS, INC. Directeur/Membre du Conseil 01/03/2017
ADAPTIMMUNE THERAPEUTICS PLC Directeur/Membre du Conseil 01/06/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/06/2025
Corporate Officer/Principal 17/03/2010
Corporate Officer/Principal 01/01/2003

Anciens postes connus de Garry Menzel

SociétésPosteFin
STOKE THERAPEUTICS, INC. Directeur/Membre du Conseil 03/06/2026
Private Equity Investor 02/01/2026
TCR2 THERAPEUTICS INC. Directeur Général 01/01/2023
░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Garry Menzel

Formation de Garry Menzel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

95

Relations au 1er degré

20

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées20

Health Services

Health Technology

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Garry Menzel
🔇